二甲双胍,21世纪的阿司匹林:其在妊娠期糖尿病、子痫前期与癌症预防及促进长寿中的作用
本文概述二甲双胍在糖尿病治疗中的历史,回顾其在妊娠期糖尿病及肥胖非糖尿病孕妇预防巨大儿方面的荟萃分析结果,并重点介绍一项随机临床试验:早孕期给予二甲双胍未减少大于胎龄儿(主要终点),但降低了子痫前期(次要终点)的发生频率。文章还讨论其可能通过减少抗血管生成因子产生、改善内皮功能障碍及影响线粒体等机制预防子痫前期,并简述其作为癌症化疗辅助剂及延寿抗衰老的新文献。
要点
- 早孕期二甲双胍未减少大于胎龄儿(主要终点),但降低了子痫前期(次要终点)频率。
- 二甲双胍可能通过减少可溶性血管内皮生长因子受体-1和可溶性内皮糖蛋白产生、改善内皮功能障碍预防子痫前期。
- 二甲双胍分子量129道尔顿,可轻易通过胎盘,有相当证据表明孕期使用安全。
核心结论
- 实验研究和随机临床试验观察提示二甲双胍可能在子痫前期的治疗或预防中占有一席之地。
- 早孕期给予二甲双胍未减少大于胎龄儿频率(主要终点),但降低了子痫前期频率(次要终点)。
研究设计与样本
- 本文为综述,概述二甲双胍治疗糖尿病的历史,回顾其在妊娠期糖尿病及肥胖非糖尿病孕妇中预防巨大儿的荟萃分析结果,并重点介绍一项随机临床试验。
主要发现
- 早孕期给予二甲双胍未减少大于胎龄儿频率(主要终点),但降低了子痫前期频率(次要终点)。
- 二甲双胍预防子痫前期的机制包括减少抗血管生成因子(可溶性血管内皮生长因子受体-1和可溶性内皮糖蛋白)的产生及改善内皮功能障碍,可能通过影响线粒体实现。
- 另一潜在机制是二甲双胍通过雷帕霉素 mechanistic target 介导的细胞稳态与能量处置调节发挥作用。
- 二甲双胍分子量为129道尔顿,因此可轻易通过胎盘;有相当证据表明该药在孕期是安全的。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Metformin is everywhere. Originally introduced in clinical practice as an antidiabetic agent, its role as a therapeutic agent is expanding to include treatment of prediabetes mellitus, gestational diabetes mellitus, and polycystic ovarian disease; more recently, experimental studies and observations in randomized clinical trials suggest that metformin could have a place in the treatment or prevention of preeclampsia. This article provides a brief overview of the history of metformin in the treatment of diabetes mellitus and reviews the results of metaanalyses of metformin in gestational diabetes mellitus as well as the treatment of obese, non-diabetic, pregnant women to prevent macrosomia. We highlight the results of a randomized clinical trial in which metformin administration in early pregnancy did not reduce the frequency of large-for-gestational-age infants (the primary endpoint) but did decrease the frequency of preeclampsia (a secondary endpoint). The mechanisms by which metformin may prevent preeclampsia include a reduction in the production of antiangiogenic factors (soluble vascular endothelial growth factor receptor-1 and soluble endoglin) and the improvement of endothelial dysfunction, probably through an effect on the mitochondria. Another potential mechanism whereby metformin may play a role in the prevention of preeclampsia is its ability to modify cellular homeostasis and energy disposition, mediated by rapamycin, a mechanistic target. Metformin has a molecular weight of 129 Daltons and therefore readily crosses the placenta. There is considerable evidence to suggest that this agent is safe during pregnancy. New literature on the role of metformin as a chemotherapeutic adjuvant in the prevention of cancer and in prolonging life and protecting against aging is reviewed briefly. Herein, we discuss the mechanisms of action and potential benefits of metformin.
引用
- Romero R, Erez O, Hüttemann M, et al. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol. 2017. PMID: 28619690. doi:10.1016/j.ajog.2017.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。